Inventor · disambiguated record
Peter Colosi
Also filed as: COLOSI PETER · COLOSI PETER C · COLOSI PETER CAMERON
33 granted patents·27 pending applications·1,333 citations·filing 1994–2025
98Inventor score
Top patents by PatentIndex Score
60 records- 0198US6001650AHigh-efficiency wild-type-free AAV helper functionsAVIGEN INC·Filed 1998·Granted Dec 14, 1999·259 cites·25 claims
- 0296US9504762B2Adeno-associated virus factor VIII vectorsBIOMARIN PHARM INC·Filed 2014·Granted Nov 29, 2016·28 cites·9 claims
- 0396US6531456B1Gene therapy for the treatment of solid tumors using recombinant adeno-associated virus vectorsAVIGEN INC·Filed 2000·Granted Mar 11, 2003·75 cites·11 claims
- 0496US5952221AAdeno-associated virus vectors comprising a first and second nucleic acid sequenceAVIGEN INC·Filed 1997·Granted Sep 14, 1999·115 cites·6 claims
- 0595US6200560B1Adeno-associated virus vectors for expression of factor VIII by target cellsAVIGEN INC·Filed 1999·Granted Mar 13, 2001·179 cites·25 claims
- 0694US7259151B2AAV virions with decreased immunoreactivity and uses thereforGENZYME CORP·Filed 2004·Granted Aug 21, 2007·54 cites·24 claims
- 0794US7125705B2Polynucleotides for use in recombinant adeno-associated virus virion productionGENZYME CORP·Filed 2001·Granted Oct 24, 2006·38 cites·18 claims
- 0893US6376237B1High-efficiency wild-type-free AAV helper functionsAVIGEN INC·Filed 1999·Granted Apr 23, 2002·96 cites·17 claims
- 0993US6221349B1Adeno-associated vectors for expression of factor VIII by target cellsAVIGEN INC·Filed 1999·Granted Apr 24, 2001·136 cites·25 claims
- 1092US9506083B2AAV virions with decreased immunoreactivity and uses thereforARBETMAN ALEJANDRA ELENA·Filed 2007·Granted Nov 29, 2016·42 cites·27 claims
- 1192US6004797AAdenovirus helper-free recombinant AAV Virion productionAVIGEN INC·Filed 1996·Granted Dec 21, 1999·95 cites·10 claims
- 1291US11083800B2AAV virions with decreased immunoreactivity and uses thereforGENZYME CORP·Filed 2019·Granted Aug 10, 2021·3 cites·15 claims
- 1391US10512675B2Adeno-associated virus factor VIII vectors, associated viral particles and therapeutic formulations comprising the sameBIOMARIN PHARM INC·Filed 2016·Granted Dec 24, 2019·9 cites·25 claims
- 1489US7351577B2Adeno-associated vector compositions for expression of Factor VIIIGENZYME CORP·Filed 2003·Granted Apr 1, 2008·15 cites·2 claims
- 1585US10463718B2Adeno-associated virus factor VIII vectorsBIOMARIN PHARM INC·Filed 2016·Granted Nov 5, 2019·3 cites·10 claims
- 1683US12239692B2Adeno-associated virus factor VIII vectorsBIOMARIN PHARM INC·Filed 2022·Granted Mar 4, 2025·0 cites·5 claims
- 1783US10350306B2Methods and compositions for treating genetically linked diseases of the eyeUS HEALTH·Filed 2018·Granted Jul 16, 2019·7 cites·13 claims
- 1883US6027931AHigh-efficiency AA V helper functionsAVIGEN INC·Filed 1998·Granted Feb 22, 2000·45 cites·12 claims
- 1981US9873893B2Methods and compositions for treating genetically linked diseases of the eyeUS HEALTH·Filed 2014·Granted Jan 23, 2018·5 cites·14 claims
- 2081US7485458B2Accessory functions for use in recombinant AAV virion productionGENZYME CORP·Filed 2005·Granted Feb 3, 2009·2 cites·27 claims
- 2181US5945335AAdenovirus helper-free system for producing recombinant AAV virions lacking oncogenic sequencesAVIGEN INC·Filed 1998·Granted Aug 31, 1999·45 cites·21 claims
- 2280US7037713B2High-efficiency wild-type-free AAV helper functionsAVIGEN INC·Filed 2002·Granted May 2, 2006·4 cites·12 claims
- 2379US7851195B2High-efficiency wild-type-free AAV helper functionsGENZYME CORP·Filed 2008·Granted Dec 14, 2010·1 cites·9 claims
- 2479US6365403B1High-efficiency AAV helper functionsAVIGEN INC·Filed 1999·Granted Apr 2, 2002·21 cites·13 claims
- 2578US2024317813A1Adeno-associated virus capsid proteinsBIOMARIN PHARM INC·Filed 2024·Application pending·0 cites
- 2677US2024058423A1Adeno-Associated Virus Factor VIII Vectors, Associated Viral Particles and Therapeutic Formulations Comprising the SameBIOMARIN PHARM INC·Filed 2023·Application pending·0 cites
- 2776US11690898B2Adeno-associated virus Factor VIII vectors, associated viral particles and therapeutic formulations comprising the sameBIOMARIN PHARM INC·Filed 2019·Granted Jul 4, 2023·0 cites·6 claims
- 2876US11406690B2Adeno-associated virus factor VIII vectorsBIOMARIN PHARM INC·Filed 2019·Granted Aug 9, 2022·0 cites·5 claims
- 2976US6218180B1Gene therapy for the treatment of solid tumors using recombinant adeno-associated virus vectorsAVIGEN INC·Filed 1999·Granted Apr 17, 2001·25 cites·14 claims
- 3076US2025332224A1Adeno-Associated Virus Factor VIII VectorsBIOMARIN PHARM INC·Filed 2025·Application pending·0 cites
- 3175US6897063B2Accessory functions for use in recombinant AAV virion productionAVIGEN INC·Filed 2002·Granted May 24, 2005·2 cites·18 claims
- 3275US2023322864A1Novel adeno-associated virus capsid proteinsBIOMARIN PHARM INC·Filed 2022·Application pending·0 cites
- 3375US2022016264A1Aav virions with decreased immunoreactivity and uses thereforGENZYME CORP·Filed 2021·Application pending·0 cites
- 3472US2024200096A1Methods of redosing gene therapy vectorsBIOMARIN PHARM INC·Filed 2023·Application pending·0 cites
- 3569US5688763ACompositions and methods for the synthesis of growth hormone receptor and growth hormone binding proteinFiled 1994·Granted Nov 18, 1997·27 cites·16 claims
- 3665US2024408240A1Treatment of hereditary angioedema with aav gene therapy vectors and therapeutic formulationsBIOMARIN PHARM INC·Filed 2022·Application pending·0 cites
- 3763US2004018627A1High-efficiency AAV helper functionsAVIGEN INC·Filed 2003·Application pending·0 cites
- 3862US2018280540A1Aav virions with decreased immunoreactivity and uses thereforGENZYME CORP·Filed 2017·Application pending·0 cites
- 3961US2006094116A1High-efficiency wild-type-free AAV helper functionsAVIGEN INC·Filed 2005·Application pending·0 cites
- 4060US2006003453A1High-efficiency AAV helper functionsAVIGEN INC·Filed 2005·Application pending·0 cites
- 4159US2003099618A1Recombinant adeno-associated vector-mediated delivery of B-domain-deleted factor VIII constructs for the treatment of hemophiliaFiled 2002·Application pending·0 cites
- 4259US2003223971A1Gene therapy for the treatment of solid tumors using recombinant adeno-associated virus vectorsFiled 2003·Application pending·0 cites
- 4359US2017232117A1Aav virions with decreased immunoreactivity and uses thereforGENZYME CORP·Filed 2016·Application pending·0 cites
- 4458US11584780B2Adeno-associated virus capsid proteinsBIOMARIN PHARM INC·Filed 2017·Granted Feb 21, 2023·0 cites·37 claims
- 4558US2002115189A1High-efficiency AAV helper functionsAVIGEN INC·Filed 2001·Application pending·0 cites
- 4657US2020362368A1Methods of redosing gene therapy vectorsBIOMARIN PHARM INC·Filed 2020·Application pending·0 cites
- 4756US2025122530A1Aav capsid compositions and methods for deliveryBIOMARIN PHARM INC·Filed 2022·Application pending·0 cites
- 4856US2024384242A1Aav capsid compositions and methods for deliveryBIOMARIN PHARM INC·Filed 2022·Application pending·0 cites
- 4956US2024376496A1Aav capsid compositions and methods for deliveryBIOMARIN PHARM INC·Filed 2022·Application pending·0 cites
- 5056US2024376495A1Aav capsid compositions and methods for deliveryBIOMARIN PHARM INC·Filed 2022·Application pending·0 cites
Showing the top 50 of 60 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →